Salarius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor.
CEOFrederick E. Pierce
CEOFrederick E. Pierce
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2014
Founded2014
Employees2
Employees2
SLRX Key Statistics
Market cap5.48M
Market cap5.48M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume1.01M
Average volume1.01M
High today$0.97
High today$0.97
Low today$0.90
Low today$0.90
Open price$0.9202
Open price$0.9202
Volume276.81K
Volume276.81K
52 Week high$108.00
52 Week high$108.00
52 Week low$0.7106
52 Week low$0.7106
Stock Snapshot
As of today, Salarius Pharmaceuticals(SLRX) shares are valued at $0.92. The company's market cap stands at 5.48M, with a P/E ratio of -0.02.
On 2025-11-29, Salarius Pharmaceuticals(SLRX) stock moved within a range of $0.90 to $0.97. With shares now at $0.92, the stock is trading +2.7% above its intraday low and -4.7% below the session's peak.
Trading volume for Salarius Pharmaceuticals(SLRX) stock has reached 276.81K, versus its average volume of 1.01M.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $108.00 and a low of $0.71.
Over the past 52 weeks, Salarius Pharmaceuticals(SLRX) stock has traded between a high of $108.00 and a low of $0.71.
People also own
Based on the portfolios of people who own SLRX. This list is generated using Robinhood data, and it’s not a recommendation.